Variant "ABCB4:c.523A>G(p.Thr175Ala)"
Search results: 3 records
Variant information
Gene:
Variant:
ABCB4:c.523A>G(p.Thr175Ala) 
Genomic location:
chr7:87082273(hg19) 
HGVS:
SO Term RefSeq
protein_coding NM_018849.2:c.523A>G(p.Thr175Ala)
protein_coding NM_000443.3:c.523A>G(p.Thr175Ala)
protein_coding NM_018850.2:c.523A>G(p.Thr175Ala)
Alias:
ABCB4:p.T175A, ABCB4:c.523A>G 
dbSNP ID:
GWAS trait:
no data 
Modifier statisitcs
Record:
Disorder:
Reference:
Effect type:
Expressivity(2) ,Penetrance(1)  
Modifier effect:
Altered gene activity(1) ,Altered incidence(1) ,Altered severity(1)  
Details:
  • Target disease:
    Atrial Fibrillation (DOID_0060224)
    Effect type:
    Expressivity 
    Modifier effect:
    Altered severity 
    Evidence:
    0.05 vs. 0.01; OR=3.73; 95% CI: 1.16-11.49; P=0.013 
    Effect:
    rs58238559 in ABCB4 is a rare missense variant with a significant effect on the development of AFL/AF.
    Alias in reference:
    ABCB4:c.523A>G(p.Thr175Ala)
    Reference:
    Title:
    Exome sequencing of a family with lone, autosomal dominant atrial flutter identifies a rare variation in ABCB4 significantly enriched in cases.
    Species studied:
    Human
    Abstract:
    Lone atrial flutter (AFL) and atrial fibrillation (AF) are common and sometimes consequential cardiac conduction disorders with a strong heritability, as underlined by recent genome-wide association studies that identified genetic modifiers. Follow-up family-based genetic analysis also identified Mendelian transmission of disease alleles. Three affected members were exome-sequenced for the identification of potential causative mutations, which were subsequently validated by direct sequencing in the other 3 affected members. Taqman assay was then used to confirm the role of any mutation in an independent population of sporadic lone AFL/AF cases.
  • Target disease:
    Cystic fibrosis (DOID_1485)
    Effect type:
    Penetrance 
    Modifier effect:
    Altered incidence 
    Evidence:
    Assessment of genotype–phenotype associations 
    Effect:
    May enhance the activity of the protein and thus exert a protective effect toward liver disease
    Alias in reference:
    ABCB4:c.523A>G
    Reference:
    Title:
    An MBL2 haplotype and ABCB4 variants modulate the risk of liver disease in cystic fibrosis patients: a multicentre study.
    Species studied:
    Human
    Abstract:
    Cystic fibrosis is the most common lethal recessive disorder among Caucasians. Over 1500 mutations have been identified in cystic fibrosis transmembrane conductance regulator disease-gene so far. A large variability of the clinical phenotype has been observed both in cystic fibrosis patients bearing the same genotype, and in affected sibpairs. Thus, genes inherited independently from cystic fibrosis transmembrane conductance regulator could modulate the clinical expression of cystic fibrosis.
  • Target disease:
    Effect type:
    Expressivity 
    Modifier effect:
    Altered gene activity 
    Evidence:
    Gene activity study 
    Effect:
    The mutation should result in substantial impairment of ABCB4 floppase activity
    Alias in reference:
    ABCB4:p.T175A
    Reference:
    Title:
    Molecular characterization and structural implications of 25 new ABCB4 mutations in progressive familial intrahepatic cholestasis type 3 (PFIC3).
    Species studied:
    Human
    Abstract:
    Progressive familial intrahepatic cholestasis type 3 (PFIC3) is an autosomal-recessive disorder due to mutations in the ATP-binding cassette, subfamily B, member 4 gene (ABCB4). ABCB4 is the liver-specific membrane transporter of phosphatidylcholine, a major and exclusive component of mammalian bile. The disease is characterized by early onset of cholestasis with high serum gamma-glutamyltranspeptidase activity, which progresses into cirrhosis and liver failure before adulthood. Presently, about 20 distinct ABCB4 mutations associated to PFIC3 have been described. We report the molecular characterization of 68 PFIC3 index cases enrolled in a multicenter study, which represents the largest cohort of PFIC3 patients screened for ABCB4 mutations to date. We observed 31 mutated ABCB4 alleles in 18 index cases with 29 distinct mutations, 25 of which are novel. Despite the lack of structural information on the ABCB4 protein, the elucidation of the three-dimensional structure of bacterial homolog allows the three-dimensional model of ABCB4 to be built by homology modeling and the position of the mutated amino-acids in the protein tertiary structure to be located. In a significant fraction of the cases reported in this study, the mutation should result in substantial impairment of ABCB4 floppase activity. The results of this study provide evidence of the broad allelic heterogeneity of the disease, with causative mutations spread along 14 of the 27 coding exons, but with higher prevalence on exon 17 that, as recently shown for the closely related paralogous ABCB1 gene, could contain an evolutionary marker for mammalian ABCB4 genes in the seventh transmembrane segment.